Narrative review / 2011
Current evidence indicates no role for oral DHEA supplementation in healthy, postmenopausal women.
This review examined published literature on DHEA supplementation in postmenopausal women. Daily oral DHEA achieves serum levels seen in women in their 20s. Interventional trials show no improvement in atherosclerosis or cardiovascular risk factors, and demonstrate a lowering of HDL cholesterol levels. DHEA modestly increases bone mineral density with adjuvant therapies and improves cognition in women with mild-to-moderate cognitive impairment, but not unimpaired women; intravaginal, but not oral, DHEA improves vaginal atrophy and sexual function.
- Study type
- Narrative review
- Who was studied
- Postmenopausal women
- What was measured
- Cardiovascular risk, bone mineral density, cognition, vaginal atrophy, sexual function
THE PAPER
Dehydroepiandrosterone sulfate and postmenopausal women.
Goel RM, Cappola AR. Curr Opin Endocrinol Diabetes Obes, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.